All Stories

  1. Reduction of planned cesarean delivery in twin pregnancy after a training intervention.
  2. Risk factors, prenatal diagnosis, and outcome of posterior placenta accreta spectrum disorders in patients with placenta previa or low‐lying placenta: A multicenter study
  3. What is the role of intrauterine transfusion after single intrauterine death in monochorionic twin pregnancies? Evidence from a systematic review and meta-analysis
  4. First‐trimester ultrasound markers for prediction of adverse outcome in monochorionic diamniotic twin pregnancy
  5. Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus
  6. Spontaneous conception and pregnancy outcomes after multi‐agent chemotherapy and high‐dose radiotherapy for pelvic Ewing sarcoma: Case report and literature review
  7. Risk of Congenital Toxoplasmosis in Newborns from Mothers with Documented Infection: Experience from Two Referral Centres
  8. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women
  9. Serendipitous diagnosis of severe fetomaternal hemorrhage through maternal AB0 discrepancy
  10. Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus
  11. Digital vs formal teaching of vaginal breech delivery: Which is the residents’ choice?
  12. Routine ultrasound does not improve instrument placement at operative vaginal delivery: An updated systematic review and meta‐analysis
  13. Maternal vaccination against COVID-19 and neonatal outcomes during Omicron: INTERCOVID-2022 study
  14. The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO)
  15. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis
  16. Development and validation of a prognostic model to predict birth weight: individual participant data meta-analysis
  17. MV‐flow in the assessment of fetal vein of Galen aneurysmal malformation
  18. European association of perinatal medicine (EAPM) position statement: Screening, diagnosis and management of congenital anomalies of the umbilical cord
  19. Exploring the mystical relationship between the Moon, Sun, and birth rate
  20. Prenatal diagnosis of multiple gastric duplication cysts
  21. First-trimester cesarean scar pregnancy: a comparative analysis of treatment options from the international registry
  22. Intrapartum pyrexia, cardiotocography traces and histologic chorioamnionitis: a case-control study
  23. Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Preeclampsia and Italian Society of Perinatal Medicine
  24. Determinants of emergency Cesarean delivery in pregnancies complicated by placenta previa with or without placenta accreta spectrum disorder: analysis of ADoPAD cohort
  25. Timing of cesarean delivery for fetal heart rate abnormalities in hypertensive pregnancies induced with oral misoprostol or Foley catheter: Secondary analysis of a randomized clinical trial
  26. ISUOG Practice Guidelines: performance of third‐trimester obstetric ultrasound scan
  27. Perinatal care in SARS-CoV-2 infected women: the lesson learnt from a national prospective cohort study during the pandemic in Italy
  28. Inherited episodic ataxia type 2 in pregnancy: A case report
  29. Indications for fetal echocardiography: Italian Society of Ultrasound in Obstetrics and Gynecology (SIEOG) guidelines using GRADE methodology
  30. Management of preterm labor: Clinical practice guideline and recommendation by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation
  31. Comparison of practice vs theory model training for vacuum-assisted delivery: A randomized controlled trial
  32. Do differences in diagnostic criteria for late fetal growth restriction matter?
  33. Treatment of Early Cesarean Scar Pregnancy with Double Balloon Catheter: A Systematic Review of the Literature
  34. EP16.20: Consensus protocol for diagnosis and management of singleton pregnancies with vasa previa: interim findings from a Delphi study
  35. Perinatal outcome of monochorionic triamniotic triplet pregnancy: multicenter cohort study
  36. Small‐for‐gestational‐age fetus diagnosed in the second trimester: Possible etiologies and short‐term neonatal outcomes
  37. Hepatocellular carcinoma in pregnancy: A systematic review
  38. ISUOG Practice Guidelines (updated): fetal cardiac screening
  39. Reduced prevalence of fetal exposure to alcohol in Italy: a nationwide survey
  40. Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system
  41. Obliterated cavum septi pellucidi: Clinical significance and role of fetal magnetic resonance
  42. Identification of bi‐allelic LFNG variants in three patients and further clinical and molecular refinement of spondylocostal dysostosis 3
  43. Editorial: Hypertensive disorders of pregnancy and the cardiovascular system: Causes, consequences, prevention and treatment
  44. Anthropometric Features and Third-Fourth Degree Perineal Tears
  45. Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis
  46. Corrigendum to “The Italian guidelines on ultrasound in obstetrics and gynecology: Executive summary of recommendations for practice” [Eur. J. Obstetrics Gynecol. 279 (2022) 176–182]
  47. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum
  48. Role of fetal magnetic resonance imaging in fetuses with congenital cytomegalovirus infection: multicenter study
  49. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study
  50. Reduced fetal growth velocity and weight loss are associated with adverse perinatal outcome in fetuses at risk of growth restriction
  51. Prognostic Value of Amniotic Fluid Viral Load to Predict Adverse Outcome in Pregnancies Complicated by Congenital Cytomegalovirus Infection: A Multicenter Study
  52. Application of IOTA stepwise diagnostic flowchart to fetal anomalies: INDIAMAN‐20 (INstant DIAgnoses of Major ANomalies) protocol
  53. Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2 198 655 pregnancies
  54. Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort
  55. Sex-dependent association between variability in infants’ OXTR methylation at birth and negative affectivity at 3 months
  56. Referral scan for congenital anomalies: time to agree on indications
  57. Current practice in the diagnosis and management of fetal growth restriction: An international survey
  58. Post-partum Women’s Anxiety and Parenting Stress: Home-Visiting Protective Effect During the COVID-19 Pandemic
  59. Maternal and infant NR3C1 and SLC6A4 epigenetic signatures of the COVID-19 pandemic lockdown: when timing matters
  60. Maternal Right Ventricular and Left Atrial Function in Uncomplicated Twin Pregnancies: A Longitudinal Study
  61. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies
  62. Maternal Left Ventricular Function in Uncomplicated Twin Pregnancies: A Speckle-Tracking Imaging Longitudinal Study
  63. Third‐trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study
  64. Effects of prenatal exposure to maternal COVID-19 and perinatal care on neonatal outcome: results from the INTERCOVID Multinational Cohort Study
  65. Risk factors for anxiety and depression among pregnant women during COVID ‐19 pandemic—Results of a web‐based multinational cross‐sectional study
  66. Is Brain-Derived Neurotropic Factor Methylation Involved in the Association Between Prenatal Stress and Maternal Postnatal Anxiety During the COVID-19 Pandemic?
  67. An update of diagnostic efficacy of ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders
  68. Diabetes mellitus, maternal adiposity, and insulin-dependent gestational diabetes are associated with COVID-19 in pregnancy: the INTERCOVID study
  69. Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study)
  70. Ultrasound and MRI appearance of abnormally adherent placenta in a woman with Asherman's syndrome
  71. Incidence, clinical features and perinatal outcome in anomalous fetuses with late‐onset growth restriction: cohort study
  72. ISUOG Practice Guidelines (updated): performance of the routine mid‐trimester fetal ultrasound scan
  73. Timing of intra‐fetal laser therapy for twin reversed arterial perfusion ( TRAP ) sequence: Retrospective series and systematic review and meta‐analysis
  74. Chorionicity, birth weight discordance and neonatal morbidity in uncomplicated twin pregnancies delivered from 36 weeks
  75. Not yet the last word on fundal pressure
  76. Perinatal and 2-year neurodevelopmental outcome in late preterm fetal compromise: the TRUFFLE 2 randomised trial protocol
  77. Exclusive breastfeeding and maternal postnatal anxiety contributed to infants' temperament issues at 6 months of age
  78. Inappropriate left ventricular mass after HELLP syndrome inappropriate LVM after HELLP syndrome
  79. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study
  80. Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach
  81. Organization of an obstetrics unit during the COVID-19 pandemic: a short literature review
  82. HLA class I and HPA9b related fetal‐neonatal alloimmune thrombocytopenia
  83. Obstetric consequences of a false‐positive diagnosis of large‐for‐gestational‐age fetus
  84. Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders
  85. Uterine artery Doppler for the prediction of outcome in pregnancies complicated by hypertensive disorders of pregnancy
  86. In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19
  87. Role of prenatal magnetic resonance imaging in fetuses with isolated severe ventriculomegaly at neurosonography: A multicenter study
  88. Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case–control study in Italy (the MODEL-PLACENTA study)
  89. Longitudinal Doppler Assessments in Late Preterm Fetal Growth Restriction
  90. Fetal cerebral blood‐flow redistribution: analysis of Doppler reference charts and association of different thresholds with adverse perinatal outcome
  91. Fetoscopic laser ablation therapy in monochorionic diamniotic twin pregnancies with twin-to-twin transfusion syndrome treated at a single centre over 10 years: a retrospective study
  92. Depression and Anxiety in Mothers Who Were Pregnant During the COVID-19 Outbreak in Northern Italy: The Role of Pandemic-Related Emotional Stress and Perceived Social Support
  93. Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study
  94. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study
  95. The hidden pandemic: COVID-19-related stress, SLC6A4 methylation, and infants’ temperament at 3 months
  96. External validation of prognostic models to predict stillbirth using the International Prediction of Pregnancy Complications ( IPPIC ) Network database: an individual participant data meta‐analysis
  97. Hidden pandemic: COVID-19-related stress, SLC6A4 methylation, and infants’ temperament at 3 months
  98. ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics
  99. Prenatal maternal stress during the COVID-19 pandemic and infant regulatory capacity at 3 months: A longitudinal study
  100. Role of prenatal magnetic resonance imaging in fetuses with isolated anomalies of corpus callosum: multinational study
  101. Maternal myocardial dysfunction after hemolysis, elevated liver enzymes, and low platelets syndrome: a speckle-tracking study
  102. Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review
  103. Pre-eclampsia and late fetal growth restriction
  104. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection
  105. Childbirth Care among SARS-CoV-2 Positive Women in Italy
  106. Maternal and neonatal outcomes of pregnancies complicated by late fetal growth restriction undergoing induction of labor with dinoprostone compared with cervical balloon: A retrospective, international study
  107. Pregnancy and COVID‐19: Do not overlook malaria
  108. Maternal hemodynamics, arterial stiffness and elastic aortic properties in twin pregnancy
  109. Measuring the Outcomes of Maternal COVID-19-related Prenatal Exposure (MOM-COPE): study protocol for a multicentric longitudinal project
  110. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
  111. Assessing risk factors for severe forms of COVID‐19 in a pregnant population: A clinical series from Lombardy, Italy
  112. External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis
  113. The Impact of Preeclampsia on Women’s Health: Cardiovascular Long-term Implications
  114. Prenatal diagnosis of fetal anomalies from the third to the first trimester and back
  115. Retest positive for SARS‐CoV‐2 RNA of recovered pregnant women with COVID‐19
  116. Pregnancy prolongation for pre‐eclampsia: the obvious and the avoidable
  117. The MOM-COPE research project: Measuring the outcomes of maternal COVID19-related prenatal exposure
  118. Possible Coronavirus Disease 2019 Pandemic and Pregnancy
  119. SARS-CoV-2 infection testing at delivery: a clinical and epidemiological priority
  120. Standardising definitions for the pre-eclampsia core outcome set: A consensus development study
  121. Folic Acid Supplementation in Pregnancy
  122. Outcomes in Pregnancies With a Confined Placental Mosaicism and Implications for Prenatal Screening Using Cell-Free DNA
  123. Fetal cerebral Doppler changes and outcome in late preterm fetal growth restriction: prospective cohort study
  124. Maternal myocardial dysfunction after normotensive fetal growth restriction compared with hypertensive pregnancies: a speckle-tracking study
  125. Current use and performance of the different fetal growth charts in the Italian population
  126. ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in context of COVID‐19
  127. ISUOG Interim Guidance on coronavirus disease 2019 (COVID‐19) during pregnancy and puerperium: information for healthcare professionals – an update
  128. Vaginal delivery in SARS‐CoV‐2‐infected pregnant women in Northern Italy: a retrospective analysis
  129. COVID ‐19 Obstetrics Task Force, Lombardy, Italy: Executive management summary and short report of outcome
  130. A core outcome set for pre‐eclampsia research: An international consensus development study
  131. ISUOG Practice Guidelines: role of ultrasound in congenital infection
  132. Twin Reversed Arterial Perfusion Sequence: Current Treatment Options
  133. Identification of large-for-gestational age fetuses using antenatal customized fetal growth charts: Can we improve the prediction of abnormal labor course?
  134. Reply
  135. External validation of a simple risk score based on the ASPRE trial algorithm for preterm pre‐eclampsia considering maternal characteristics in nulliparous pregnant women: a multicentre retrospective cohort study
  136. Core outcome set for studies investigating management of selective fetal growth restriction in twins
  137. A case of combined aortic bioprosthetic valve degeneration and patient–prosthesis mismatch during pregnancy
  138. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals
  139. Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular Morbidity
  140. Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: a multicenter study
  141. Genome‐wide cfDNA testing of maternal blood
  142. Antepartum and intrapartum risk factors for neonatal hypoxic–ischemic encephalopathy
  143. Ductus venosus Doppler waveform pattern in fetuses with early growth restriction
  144. Perinatal outcomes of fetal intra-abdominal umbilical vein varix: a multicenter cohort study
  145. Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses
  146. Outcome of twin‐to‐twin transfusion syndrome in monochorionic monoamniotic twin pregnancies: a systematic review and meta‐analysis
  147. Prenatal ultrasound diagnosis of cavitation of ganglionic eminence
  148. Higher rate of early-onset preeclampsia in pregnancies following oocyte donation according to increasing maternal age
  149. Intracervical lakes as a sonographic marker of placenta accreta spectrum (PAS) in patients with previa and low‐lying placenta
  150. Effects of Antenatal Betamethasone on Fetal Doppler Indices and Short Term Fetal Heart Rate Variation in Early Growth Restricted Fetuses
  151. Agreement between anatomical M‐mode and tissue Doppler imaging in the assessment of fetal atrioventricular annular plane displacement in uncomplicated pregnancies: A prospective longitudinal study
  152. Ultrasound evaluation of left ventricular and aortic fibrosis after HELLP syndrome
  153. Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA
  154. Prenatal findings in oral‐facial‐digital syndrome type VI: Report of three cases and literature review
  155. Fetal anemia: Diagnosis and management
  156. Interobserver variability in MRI assessment of the severity of placenta accreta spectrum disorders
  157. Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert
  158. The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis
  159. Early Intraperitoneal Transfusion for Fetal Hydrops Caused by Parvovirus B19 Infection
  160. Evaluation of the quality and reliability of middle cerebral artery and umbilical artery Doppler images within an international randomized controlled trial
  161. Maternal blood flow to the placenta
  162. Opportunistic salpingectomy during postpartum contraception procedures at elective and unscheduled cesarean delivery
  163. Weight discordance and perinatal mortality in monoamniotic twin pregnancies: analysis of the MONOMONO, NorSTAMP and STORK multiple pregnancy cohorts
  164. Comparative analysis of the 2‐year outcomes in the GRIT and TRUFFLE trials
  165. Birthweight discordance and neonatal morbidity in twin pregnancies: A systematic review and meta‐analysis
  166. Comparison of two “a priori” risk assessment algorithms for preeclampsia in Italy: a prospective multicenter study
  167. Perinatal mortality, timing of delivery and prenatal management of monoamniotic twin pregnancy: systematic review and meta‐analysis
  168. Elastic properties of ascending aorta and ventricular–arterial coupling in women with previous pregnancy complicated by HELLP syndrome
  169. The use of ultrasound-indicated cerclage or cervical pessary in asymptomatic twin pregnancies with a short cervix at midgestation
  170. TRAP Sequence in Monochorionic/Monoamniotic (MC/MA) Discordant Twins: Two Cases Treated with Fetoscopic Laser Surgery
  171. Ultrasonography Diagnosis
  172. Inappropriate left ventricular mass after preeclampsia: another piece of the puzzle Inappropriate LVM and PE
  173. Randomised Italian Sonography for occiput POSition Trial Ante vacuum (R.I.S.POS.T.A.)
  174. Maternal functional hemodynamics in uncomplicated twin pregnancies: a longitudinal study using impedance cardiography
  175. Ultrasound evaluation of left ventricular and aortic fibrosis after pre-eclampsia
  176. Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study
  177. PMD38 - CELL-FREE FETAL DNA AS A CONTINGENT PRENATAL SCREENING OF TRISOMIES CONDITIONAL TO A RISK ≥ 1:1,000 FOR ITALIAN PREGNANT WOMEN: AN ECONOMIC EVALUATION
  178. Atypical presentation and imaging features of postpartum posterior reversible encephalopathy syndrome
  179. Pre-eclampsia and heart failure: a close relationship
  180. The Effect of Chorionicity on Maternal Cardiac Adaptation to Uncomplicated Twin Pregnancy: A Prospective Longitudinal Study
  181. Prophylaxis for Fetal Growth Restriction: Aspirin and Low-Molecular-Weight Heparins
  182. Planned Home Versus Planned Hospital Births in Women at Low-Risk Pregnancy: A Systematic Review With Meta-analysis
  183. Prenatal management and timing of delivery of uncomplicated monochorionic monoamniotic twin pregnancy: the MONOMONO study
  184. Twin-to-twin-transfusion syndrome: from amniodrainage to laser
  185. Etiology and Prognosis of Severe Ventriculomegaly Diagnosed at Late Gestation
  186. Weight discordance and perinatal mortality in twin pregnancy: systematic review and meta‐analysis
  187. Longitudinal reference ranges for serial measurements of myocardial performance index (MPI) by conventional and pulsed-wave tissue Doppler in monochorionic diamniotic twins at 17 to 26 weeks of gestation
  188. Cerebroplacental ratio before induction of labour in normally grown fetuses at term and intrapartum fetal compromise
  189. Perinatal Outcome of Fetal Umbilical Vein Varix
  190. Brain-injured Survivors of Monochorionic Twin Pregnancies Complicated by Single Intrauterine Death: MR Findings in a Multicenter Study
  191. Cervical-length measurement in mid-gestation to predict spontaneous preterm birth in asymptomatic triplet pregnancy
  192. Management of monochorionic twin pregnancy discordant for body-stalk anomaly
  193. Planned home versus planned hospital births in women at low-risk pregnancy: A systematic review with meta-analysis
  194. Endometriosis, endometrioma, and ART results: Current understanding and recommended practices
  195. Changes in ductus venosus velocity ratios after fetoscopic laser surgery for twin-twin transfusion syndrome
  196. Acetylsalicylic acid in pregnant women with chronic hypertension
  197. 122: Timing of delivery of uncomplicated monochorionic monoamniotic twins
  198. Maternal endothelial function and vascular stiffness after HELLP syndrome: a case-control study
  199. First-trimester screening for pre-eclampsia: time for reflection
  200. Maternal cardiac function after HELLP syndrome: an echocardiography study
  201. Economic Analysis of The Use of Non-Invasive Prenatal Test (NIPT) For Prenatal Screening of Trisomy 21, 18, 13 In Pregnant Women
  202. Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study
  203. Severe fetal growth restriction at 26–32 weeks: key messages from the TRUFFLE study
  204. A multi-centre, non-inferiority, randomised controlled trial to compare a cervical pessary with a cervical cerclage in the prevention of preterm delivery in women with short cervical length and a history of preterm birth – PC study
  205. Comparative X-ray morphometry of prenatal osteogenesis imperfecta type 2 and thanatophoric dysplasia: a contribution to prenatal differential diagnosis
  206. Longitudinal study of computerized cardiotocography in early fetal growth restriction
  207. How to monitor pregnancies complicated by fetal growth restriction and delivery before 32 weeks: post-hoc analysis of TRUFFLE study
  208. Early prediction of twin-to-twin transfusion syndrome: systematic review and meta-analysis
  209. Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction?
  210. Late appearance of umbilical artery end-diastolic flow in selective intrauterine growth restriction complicating monochorionic diamniotic twin pregnancy
  211. Chromosomal Microarray and Fetal Growth Restriction
  212. Correlation between fetal autopsy and prenatal diagnosis by ultrasound: A systematic review
  213. The search for the ideal microbiota in human reproduction
  214. Re: Validation of a first-trimester screening model for pre-eclampsia in an unselected population. E. Scazzocchio, F. Crovetto, S. Triunfo, E. Gratacós and F. Figueras.Ultrasound Obstet Gynecol2017; 49: 188-193.
  215. Early onset fetal growth restriction
  216. Development of Customized Fetal Growth Charts in Twins
  217. Validation of predictive models for pre-eclampsia
  218. Counselling about the Risk of Preterm Delivery: A Systematic Review
  219. Phase-rectified signal averaging method to predict perinatal outcome in infants with very preterm fetal growth restriction- a secondary analysis of TRUFFLE-trial
  220. Cervical Length at Mid-gestation in Screening for Preterm Birth in Twin Pregnancy
  221. OP17.07: Cervical length measurement at mid‐gestation to predict spontaneous preterm birth in triplet pregnancies
  222. OC02.05: Ductus venosus velocity ratios for prediction of neonatal cardiac dysfunction in early severe fetal growth restriction
  223. OC09.04: Longitudinal reference ranges for serial measurements of myocardial performance index (MPI) by conventional and tissue Doppler in monochorionic diamniotic pregnancies at 17–26 weeks of gestation
  224. P02.09: Uterine artery Doppler in the management of dichorionic twin pregnancies discordant for intrauterine growth restriction
  225. Outcomes Associated With Isolated Agenesis of the Corpus Callosum: A Meta-analysis
  226. Cervical length at mid-gestation in screening for preterm birth in twin pregnancy
  227. Surgery for endometriosis and outcome of IVF-ET: systematic review and meta-analysis
  228. Intertwin discrepancy in middle cerebral artery peak systolic velocity and third-trimester fetal growth restriction in monochorionic-diamniotic twin pregnancy
  229. Fetal heart monitoring in labour: from pinard to artificial intelligence
  230. Reply
  231. Predicting outcome in 259 fetuses with agenesis of ductus venosus – a multicenter experience and systematic review of the literature
  232. The effect of fetal sex on customized fetal growth charts
  233. Circular RNA and pre-eclampsia: on the long road from the laboratory to the bedside
  234. Elastic properties of ascending aorta in women with previous pregnancy complicated by early- or late-onset pre-eclampsia
  235. 256: Prediction of outcome in 255 fetuses with absent ductus venosus - a multicenter experience and literature review
  236. Customized Fetal Growth Charts for Parents' Characteristics, Race, and Parity by Quantile Regression Analysis
  237. Amniocentesis for fetal karyotyping: the end of an era?
  238. Placental morphology in pregnancies associated with pregravid obesity
  239. 2 Year Neurodevelopmental and Intermediate Perinatal Outcomes in Infants With Very Preterm Fetal Growth Restriction (TRUFFLE)
  240. Outcome of monochorionic diamniotic twin pregnancies followed at a single center
  241. Microwave Ablation in Complicated Monochorionic Twin Pregnancies
  242. Neonatal morbidity after cesarean section before labor at 34+0to 38+6weeks: a cohort study
  243. Polyhydramnios in sac of parasitic twin: atypical manifestation of twin reversed arterial perfusion sequence
  244. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
  245. The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus
  246. Reply: fruit and fetal brain MRI - the cherry-picking approach to systematic reviews
  247. Quality of first trimester risk prediction models for pre-eclampsia: a systematic review
  248. Re: Transverse vaginal septae: management and long-term outcomes
  249. Reply: Apples, oranges and fetal brain MRI
  250. The natural history of monoamniotic twin pregnancies: a case series and systematic review of the literature
  251. Re: Iatrogenic perforation of intertwin membrane after laser surgery for twin‐to‐twin transfusion syndrome. S. H. P. Peeters, T. T. Stolk, F. Slaghekke, J. M. Middeldorp, F. J. Klumper, E. Lopriore and D. Oepkes. Ultrasound Obstet Gynecol 2014; 44: 550...
  252. Fetal cardiac parameters for prediction of twin‐to‐twin transfusion syndrome
  253. Pregnancy outcomes of induced labor in women with previous cesarean section: a systematic review and meta-analysis
  254. OC23.05: Inter-twin discordance in mean cerebral artery peak systolic velocity and pregnancy outcome in monochorionic diamniotic twin pregnancies
  255. OP11.04: Fetal cardiac parameters for the prediction of twin-twin transfusion syndrome
  256. OP11.10: Spontaneous preterm birth in triplet pregnancies is independent from cervical length measurement at mid-gestation
  257. OP30.04: Cervical length measurement in twin pregnancies at 18-22 weeks: not the best test for all preterm births
  258. P02.15: Body stalk anomaly in monoamniotic twins at 9 weeks
  259. P14.31: First trimester risk prediction models for pre-eclampsia based on uterine artery Doppler: a systematic review of methodology
  260. P19.12: The natural history of monoamniotic twin pregnancies
  261. P19.18: Polyhydramnios in the sac of the parasitic twin: atypical manifestation of twin-reversed arterial perfusion sequence
  262. Additional value of fetal magnetic resonance imaging in the prenatal diagnosis of central nervous system anomalies: a systematic review of the literature
  263. Perinatal Outcomes of Twin Anemia–Polycythemia Sequence: A Systematic Review
  264. Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis
  265. Concordant body stalk anomaly in a monoamniotic twin pregnancy at 9 weeks
  266. Re: Uterine artery Doppler and sFlt‐1/PlGF ratio: prognostic value in early‐onset pre‐eclampsia. P. I. Gómez‐Arriaga, I. Herraiz, E. A. López‐Jiménez, D. Escribano, B. Denk and A. Galindo. Ultrasound Obstet Gynecol 2014; 43: 525–532
  267. The prognostic role of various indices and ratios of Doppler velocimetry in patients with pre-eclampsia
  268. Fetal abdominal wall defects
  269. Fetal Surgery
  270. Rapid cervical phIGFBP-1 test in asymptomatic twin pregnancies: role in mid-pregnancy prediction of spontaneous preterm delivery
  271. Fetoscopic cord transection for treatment of monoamniotic twin reversed arterial perfusion sequence
  272. 203: The effects of vanishing twin on perinatal outcomes of the co-twin: a systematic review with meta-analysis
  273. Fetal weight estimation in gestational diabetic pregnancies: comparison between conventional and three-dimensional fractional thigh volume methods using gestation-adjusted projection
  274. Accuracy of Ultrasonography at 11–14 Weeks of Gestation for Detection of Fetal Structural Anomalies
  275. Comment on “Long‐term outcomes of children with umbilical vein varix diagnosed prenatally”
  276. Prevention, Management, and Outcomes of Macrosomia
  277. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
  278. Pregnancy week at delivery and the risk of shoulder dystocia: a population study of 2 014 956 deliveries
  279. Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R
  280. Perinatal outcomes of isolated oligohydramnios at term and post-term pregnancy: a systematic review of literature with meta-analysis
  281. Preliminary experience with microwave ablation for selective feticide in monochorionic twin pregnancies
  282. Cervical cerclage in twin pregnancies
  283. The use of radiofrequency in the treatment of twin reversed arterial perfusion sequence: a case series and review of the literature
  284. Impact of cord entanglement on perinatal outcome of monoamniotic twins: a systematic review of the literature
  285. Re: Impact of cord entanglement on perinatal outcome of monoamniotic twins: a systematic review of the literature. A. C. Rossi and F. Prefumo. Ultrasound Obstet Gynecol 2013; 41: 131–135
  286. ISUOG Practice Guidelines: use of Doppler ultrasonography in obstetrics
  287. Effects of antenatal recognition and follow‐up on perinatal outcomes in small‐for‐gestational age infants delivered after 36 weeks
  288. I299 EVIDENCE‐BASED APPLICATION OF 3D/4D ULTRASOUND IN FETAL MEDICINE: OVERVIEW
  289. Re: Effect of letrozole on uterine artery Doppler flow indices prior to first-trimester termination of pregnancy: a randomized controlled trial. V. C. Y. Lee, T. W. Y. Yeung, O. S. Tang, E. H. Y. Ng, W. S. B. Yeung and P. C. Ho. Ultrasound Obstet Gynecol
  290. OP06.07: Preliminary experience with microwave ablation for selective feticide in monochorionic twin pregnancies
  291. P08.15: The role of uterine artery pulsatility index for prediction of outcome in pregnancies complicated by pre-eclampsia
  292. PP110. The role of doppler to predict adverse pregnancy outcome in patients with pre-eclampsia
  293. Conservative management in a case of iatrogenic twin anemia–polycythemia sequence
  294. Effects of Epidural Analgesia on Uterine Artery Doppler in Labor
  295. OC09.02: Complications and outcome of invasive prenatal diagnosis in twin pregnancies
  296. The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women
  297. Successful management of a triplet heterotopic caesarean scar pregnancy after in vitro fertilization-embryo transfer
  298. Nuchal translucency thickness and crown rump length discordance for the prediction of outcome in monochorionic diamniotic pregnancies
  299. Practice guidelines for performance of the routine mid‐trimester fetal ultrasound scan
  300. Effects of epidural analgesia on uterine artery Doppler in labour
  301. P19.05: Obstetric and perinatal outcomes in triplet pregnancies in relation to chorionicity
  302. OC03.05: Effects of antenatal identification on perinatal outcomes in small for gestational age infants delivered after 34 weeks' gestation
  303. P06.09: Fetoscopic laser treatment for twin–twin transfusion syndrome: preliminary results from a new Italian center
  304. OP06.01: A systematic review of first trimester nuchal translucency for the prediction of twin‐to‐twin transfusion syndrome
  305. A randomized controlled trial of 24‐hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score ≤ 4
  306. Single umbilical artery and congenital heart disease in selected and unselected populations
  307. Increased concentrations of antiangiogenic factors in mirror syndrome complicating twin‐to‐twin transfusion syndrome
  308. Stepwise sequential screening for trisomy 21 in assisted reproduction pregnancies
  309. OP11.11: Effects of epidural analgesia on uterine artery Doppler in labour
  310. P06.08: Successful management of a heterotopic twin pregnancy on Cesarean scar combined with a viable intrauterine pregnancy
  311. P26.06: Increased concentrations of antiangiogenic factors in mirror syndrome complicating TTTS
  312. P05.16: Interobserver repeatability of transabdominal 3D ultrasound of the fetal brain
  313. OC26.02: Fetal weight estimation in pregnancy complicated by obesity: comparison between conventional and a new 3D ultrasound method
  314. OP14.03: Longitudinal study of maternal insulin-like growth factor-I and uterine artery Doppler
  315. OC20.01: Cardiovascular function in women with a previous pregnancy complicated by early onset pre-eclampsia
  316. OP18.03: Nuchal translucency thickness discordance for prediction of severe twin-twin transfusion syndrome
  317. OP34.05: Outcome of monochorionic diamniotic pregnancies followed at a single Twin Clinic
  318. Interobserver Reproducibility of Transabdominal 3-Dimensional Sonography of the Fetal Brain
  319. First‐trimester uterine artery Doppler indices in the prediction of small‐for‐gestational age pregnancy and intrauterine growth restriction
  320. Association of Uterine Artery Doppler Resistance Index and Birth Weight: Effect of Customized Birth Weight Standards
  321. Adnexal torsion in late pregnancy
  322. Stepwise sequential screening for trisomy 21 in assisted reproduction pregnancies
  323. Pulse wave analysis: a preliminary study of a novel technique for the prediction of pre-eclampsia
  324. First trimester uterine artery Doppler in women with previous pre‐eclampsia
  325. Prenatal imaging of ductus venosus agenesis using 4D ultrasound with a matrix array transducer
  326. First‐trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine
  327. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin
  328. Acute Premature Constriction of the Ductus Arteriosus after Maternal Self-Medication with Nimesulide
  329. Association between birth weight and first-trimester free β–human chorionic gonadotropin and pregnancy-associated plasma protein A
  330. Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction
  331. Evaluation of fetal arrhythmias from simultaneous pulsed wave Doppler in pulmonary artery and vein
  332. Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker
  333. P41.03: Uterine artery Doppler at 10–14 weeks and maternal serum concentrations of asymmetric dimethylarginine
  334. OP01.10: Third trimester uterine artery Doppler and adverse obstetric outcome
  335. OP13.08: Corpus callosum abnormalities: 2D, 3D ultrasound and MRI
  336. P27.14: Fetal cystic hygroma and mid‐trimester maternal serum screening
  337. OP14.01: Uterine artery Doppler at 10–14 weeks and the interaction between decidual NK cells and extravillous trophoblast: an immunohistochemical study
  338. OP01.03: Maternal cardiovascular function and ambulatory blood pressure monitoring in pregnancies complicated by fetal growth restriction
  339. OC138: The combination of short cervical length and phIGFBP‐1 in the prediction of preterm delivery
  340. P32.17: Real‐time 3D ultrasound using a matrix array transducer: a case of agenesis of the ductus venosus
  341. OP19.05: A comparison of cervical length measurement and phIGFBP‐1 in the prediction of preterm delivery
  342. Cystic hygroma and mid-trimester maternal serum screening
  343. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development
  344. Matrix Array Transducers in Fetal Heart Imaging
  345. Increased Apoptosis in First Trimester Extravillous Trophoblasts from Pregnancies at Higher Risk of Developing Preeclampsia
  346. Apparently isolated borderline ventriculomegaly and lissencephaly
  347. Outcome of prenatally diagnosed agenesis of the corpus callosum
  348. First‐trimester uterine artery Doppler and spontaneous preterm delivery
  349. Analysis of Natural Killer Cells Isolated from Human Decidua: Evidence that 2B4 (CD244) Functions as an Inhibitory Receptor and Blocks NK Cell Function
  350. Maternal and neonatal outcome after failed ventouse delivery: Comparison of forceps versus cesarean section
  351. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function
  352. Maternal cardiac function in early pregnancies with high uterine artery resistance
  353. Uterine artery Doppler velocimetry at 11–14 weeks in singleton pregnancies conceived by assisted reproductive technology
  354. Correlation between first-trimester uterine artery Doppler indices and maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A
  355. Correlation between first trimester fetal bone length and maternal serum pregnancy-associated plasma protein-A (PAPP-A)
  356. P04.18: Acute premature constriction of the ductus arteriosus after maternal self‐medication with nimesulide
  357. P07.01: First‐trimester uterine artery Doppler in women with previous pre‐eclampsia
  358. OP07.01: First‐trimester uterine artery Doppler and spontaneous preterm delivery
  359. OP07.03: First‐trimester uterine artery Doppler and small‐for‐gestational‐age infants
  360. OP18.02: Contrast‐enhanced ultrasound (CEU) before and after uterine artery embolisation (UAE) for fibroid treatment
  361. P14.06: Difficult differential diagnosis of an occipital mass
  362. P07.02: First‐trimester uterine artery Doppler and pre‐eclampsia
  363. OC117: Transvaginal ultrasound (TVUS) and sonohysterography (SHG) in the preoperative staging of submucous fibroids
  364. OP13.03: Assessment of palpable nodules of the abdominal wall with postpartum onset
  365. P14.03: Prenatal diagnosis of septal agenesis with normal pituitary function
  366. P02.72: Prenatal diagnosis of Meckel–Gruber syndrome in a pregnancy deriving from ICSI
  367. OC75: Differential diagnosis of uterine myomas and adenomyosis by color Doppler (CD) and contrast‐enhanced ultrasound (CEU)
  368. Assessment of the intraobserver variability in the measurement of fetal cardiothoracic ratio using ellipse and diameter methods
  369. Prenatal Diagnosis of Meckel–Gruber Syndrome in a Pregnancy Obtained With ICSI
  370. Influence of parity on first trimester endovascular trophoblast invasion
  371. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11–14 weeks?
  372. First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations
  373. Clinical implications of an anatomical variant of the ductus venosus
  374. Effect of inter-twin delivery interval on neonatal haemoglobin concentration
  375. Prenatal diagnosis of septal agenesis with normal pituitary function
  376. Prenatal diagnosis of a nasal glioma in the mid trimester
  377. Association of first trimester uterine artery Doppler, maternal diastolic cardiac function and ischaemia modified albumin
  378. Trisomy18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result
  379. The association between p53 expression, stage and histological features in endometrial cancer
  380. P15.12: Association of first trimester uterine artery Doppler indices with maternal diastolic cardiac function
  381. OC32.02: First‐trimester uterine artery Doppler and ischaemia modified albumin in women who subsequently develop severe pre‐eclampsia
  382. A newly described thoracic vascular malformation in fetuses with Down syndrome
  383. Acute Presentation of Fetal Hypertrophic Cardiomyopathy in a Type 1 Diabetic Pregnancy
  384. First-Trimester Ductus Venosus, Nasal Bones, and Down Syndrome in a High-Risk Population
  385. Fetal congenital cardiac diverticulum with pericardial effusion: two cases with different presentations in the first trimester of pregnancy
  386. First-trimester fetal nuchal translucency and inherited metabolic disorders
  387. Prenatal sonographic findings in a case of Varadi–Papp syndrome
  388. Second‐trimester uterine artery Doppler and spontaneous preterm delivery
  389. P10.08: First trimester nasal bones and trisomy 21 in a low‐risk population
  390. P10.09: First trimester ductus venosus, nasal bones and trisomy 21 in a high‐risk population
  391. OC007: Long axis ventricular function in normal fetuses
  392. OC154: Pregnancy outcome of antenatally diagnosed agenesis of the corpus callosum
  393. OC027: Single umbilical artery and congenital heart disease in high‐ and low‐risk populations
  394. P14.42: Sonographic resolution of severe uretero‐pelvic junction obstruction in utero associated with complete absence of neonatal kidney function
  395. P11.12: Fetal Gollop‐Wolfgang complex associated with de novo chromosomal rearrangements typical of split‐hand/split‐foot anomaly
  396. OC046: The investigation of fetal arrhythmias by simultaneous pulsed wave Doppler recording of pulmonary artery and vein
  397. P08.01: Relationship of uterine artery Doppler and trophoblast invasion in the first trimester of pregnancy
  398. P01.03: Assessment of the intra‐observer variability in the measurement of fetal cardio‐thoracic ratio using ellipse and diameter methods
  399. OC065: Uterine artery resistance at 10–14 weeks of gestation is correlated with trophoblast apoptosis
  400. Oral misoprostol vs. vaginal gemeprost prior to surgical termination of pregnancy in nulliparae
  401. Ultrasound prenatal diagnosis of a lateral facial cleft (Tessier number 7)
  402. Vasa Previa: The Impact of Prenatal Diagnosis on Outcomes
  403. The Longitudinal Variation in Uterine Artery Blood Flow Pattern in Relation to Birth Weight
  404. Primary and secondary malignancies of the penis: ultrasound features
  405. Maternal ethnic origin and fetal nasal bones at 11–14 weeks of gestation
  406. Oral misoprostol vs. vaginal gemeprost prior to surgical termination of pregnancy in nulliparae
  407. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices
  408. Decreased endovascular trophoblast invasion in first-trimester pregnancies with high-resistance uterine artery doppler indices
  409. Effect of parity on second‐trimester uterine artery Doppler flow velocity and waveforms
  410. Ultrasound-guided interstitial laser therapy for the treatment of placental chorioangioma
  411. Ultrasound-Guided Interstitial Laser Therapy for the Treatment of Placental Chorioangioma
  412. First‐trimester uterine artery blood flow and birth weight
  413. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia
  414. Cardiac surgery during pregnancy: pulsatile or nonpulsatile perfusion?
  415. Early resolution of increased nuchal translucency in a fetus with trisomy 18
  416. Effect of fetal gender on first‐trimester ductus venosus blood flow
  417. Association between increased nuchal translucency and second trimester cardiac echogenic foci*1
  418. Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico-pathologic entity
  419. Association Between Increased Nuchal Translucency and Second Trimester Cardiac Echogenic Foci
  420. Early vaginal bleeding and first‐trimester markers for Down syndrome
  421. The role of oxytocin in parturition
  422. A newly recognized autosomal recessive syndrome with abnormal vertebral ossification, rib abnormalities, and nephrogenic rests
  423. Nuchal Translucency and Early Diagnosis of Congenital Anomalies
  424. Analysis of p53 and c-erbB-2 Expression in Ovarian Endometrioid Carcinomas Arising in Endometriosis
  425. OC202: Longitudinal variation of uterine artery waveforms and birthweight
  426. P300: Natural and unnatural history of first trimester cardiac diverticula
  427. P172: Ultrasound prenatal diagnosis of a lateral facial cleft (Tessier n. 7)
  428. P022: The correlation between early pregnancy ultrasound measurements and fetal nuchal translucency
  429. P020: Second trimester uterine artery Dopplers and preterm delivery
  430. P018: Maternal haematological parameters and uterine artery bloodflow
  431. OC020: Is the discriminatory zone an outdated concept?
  432. The sonographic evaluation of tubal patency with stimulated acoustic emission imaging
  433. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening
  434. Reference values for ductus venosus Doppler flow measurements at 10–14 weeks of gestation
  435. Trisomy 18 in a fetus with normal NT and abnormal maternal serum biochemistry
  436. Reference values for fetal limb biometry at 10–14 weeks of gestation
  437. Epithelial Abnormalities in Cystic Ovarian Endometriosis
  438. Comparison of First Trimester, Second Trimester and Integrated Downs Syndrome Screening Results in Unaffected Pregnancies
  439. A defective expression of ICAM-1 (CD54) on secretory endometrial cells is associated with endometriosis
  440. Isolated echogenic foci in the fetal heart: do they increase the risk of trisomy 21 in a population previously screened by nuchal translucency?
  441. Reproducibility of ductus venosus Doppler flow measurements at 11–14 weeks of gestation
  442. Prenatal diagnosis of mosaic trisomy 8 in a fetus with normal nuchal translucency thickness and reversed end‐diastolic ductus venosus flow
  443. Antenatal diagnosis of fetal intra‐abdominal umbilical vein dilatation
  444. The prenatal diagnosis of Binder syndrome before 24 weeks of gestation: case report
  445. Extent of correlation between first and second trimester markers for Down's syndrome screening
  446. Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation
  447. Reply